UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Human Endogenous Retroviruses in Neurological Diseases

Trends in molecular medicine, 2018-04, Vol.24 (4), p.379-394

2018

Volltextzugriff (PDF)

Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4

International immunology, 2015-11, Vol.27 (11), p.545-553

2015

Volltextzugriff (PDF)

The Envelope Protein of a Human Endogenous Retrovirus-W Family Activates Innate Immunity through CD14/TLR4 and Promotes Th1-Like Responses

Journal of Immunology, 2006-06, Vol.176 (12), p.7636-7644

2006

Volltextzugriff (PDF)

Induction of Proinflammatory Multiple Sclerosis-Associated Retrovirus Envelope Protein by Human Herpesvirus-6A and CD46 Receptor Engagement

Frontiers in immunology, 2018-12, Vol.9, p.2803-2803

2018

Volltextzugriff (PDF)

pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis

Proceedings of the National Academy of Sciences - PNAS, 2019-07, Vol.116 (30), p.15216-15225

2019

Volltextzugriff (PDF)

HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms

Frontiers in immunology, 2022-10, Vol.13, p.1020064-1020064

2022

Volltextzugriff (PDF)

Transgenic expression of the HERV-W envelope protein leads to polarized glial cell populations and a neurodegenerative environment

Proceedings of the National Academy of Sciences - PNAS, 2023-09, Vol.120 (38), p.1-e2308187120

2023

Volltextzugriff (PDF)

The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade

Multiple sclerosis, 2015-08, Vol.21 (9), p.1200-1203

2015

Volltextzugriff (PDF)

A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients

Multiple sclerosis, 2015-06, Vol.21 (7), p.885-893

2015

Volltextzugriff (PDF)

Variation in proviral content among human genomes mediated by LTR recombination

Mobile DNA, 2018-12, Vol.9 (1), p.36-36, Article 36

2018

Volltextzugriff (PDF)

The Human Endogenous Retrovirus Link between Genes and Environment in Multiple Sclerosis and in Multifactorial Diseases Associating Neuroinflammation

Clinical reviews in allergy & immunology, 2010-08, Vol.39 (1), p.51-61

2010

Volltextzugriff (PDF)

Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis

Translational psychiatry, 2021-07, Vol.11 (1), p.377-8, Article 377

2021

Volltextzugriff (PDF)

Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation

Annals of neurology, 2013-11, Vol.74 (5), p.721-732

2013

Volltextzugriff (PDF)

MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment

Journal of neuroimmunology, 2016-02, Vol.291, p.29-38

2016

Volltextzugriff (PDF)

A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti‐HERV‐W‐Env monoclonal antibody

Diabetes, obesity & metabolism, 2018-09, Vol.20 (9), p.2075-2084

2018

Volltextzugriff (PDF)

Rescuing the negative impact of human endogenous retrovirus envelope protein on oligodendroglial differentiation and myelination

Glia, 2019-01, Vol.67 (1), p.160-170

2019

Volltextzugriff (PDF)

Human Endogenous Retrovirus W in brain lesions: rationale for targeted therapy in Multiple Sclerosis

Multiple sclerosis and related disorders, 2016-07, Vol.8, p.11-18

2016

Volltextzugriff (PDF)

GNbAC1, a Humanized Monoclonal Antibody Against the Envelope Protein of Multiple Sclerosis—Associated Endogenous Retrovirus: A First-in-Humans Randomized Clinical Study

Clinical therapeutics, 2012-12, Vol.34 (12), p.2268-2278

2012

Volltextzugriff (PDF)

Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice

PloS one, 2013-12, Vol.8 (12), p.e80128

2013

Volltextzugriff (PDF)

Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients

EBioMedicine, 2021-04, Vol.66, p.103341-103341, Article 103341

2021

Volltextzugriff (PDF)

Human Endogenous Retrovirus K Envelope in Spinal Fluid of Amyotrophic Lateral Sclerosis Is Toxic

Annals of neurology, 2022-10, Vol.92 (4), p.545-561

2022

Volltextzugriff (PDF)

A tale of a hidden family of genetic immigrants

Microbes and infection, 2024-06, p.105387, Article 105387

Perron, Hervé

2024

Volltextzugriff (PDF)

Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein

mAbs, 2015-01, Vol.7 (1), p.265-275

2015

Volltextzugriff (PDF)

A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients — A twelve month follow-up

Journal of neuroimmunology, 2015-08, Vol.285, p.68-70

2015

Volltextzugriff (PDF)

Human Endogenous Retrovirus Type W Envelope from Multiple Sclerosis Demyelinating Lesions Shows Unique Solubility and Antigenic Characteristics

Virologica Sinica, 2021-10, Vol.36 (5), p.1006-1026

2021

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Englisch
(107)
Französisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Human Endogenous Retroviruses in Neurological Diseases

Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4

The Envelope Protein of a Human Endogenous Retrovirus-W Family Activates Innate Immunity through CD14/TLR4 and Promotes Th1-Like Responses

Induction of Proinflammatory Multiple Sclerosis-Associated Retrovirus Envelope Protein by Human Herpesvirus-6A and CD46 Receptor Engagement

pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis

HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms

Transgenic expression of the HERV-W envelope protein leads to polarized glial cell populations and a neurodegenerative environment

The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade

A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients

Variation in proviral content among human genomes mediated by LTR recombination

The Human Endogenous Retrovirus Link between Genes and Environment in Multiple Sclerosis and in Multifactorial Diseases Associating Neuroinflammation

Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis

Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation

MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment

A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti‐HERV‐W‐Env monoclonal antibody

Rescuing the negative impact of human endogenous retrovirus envelope protein on oligodendroglial differentiation and myelination

Human Endogenous Retrovirus W in brain lesions: rationale for targeted therapy in Multiple Sclerosis

GNbAC1, a Humanized Monoclonal Antibody Against the Envelope Protein of Multiple Sclerosis—Associated Endogenous Retrovirus: A First-in-Humans Randomized Clinical Study

Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice

Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients

Human Endogenous Retrovirus K Envelope in Spinal Fluid of Amyotrophic Lateral Sclerosis Is Toxic

A tale of a hidden family of genetic immigrants

Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein

A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients — A twelve month follow-up

Human Endogenous Retrovirus Type W Envelope from Multiple Sclerosis Demyelinating Lesions Shows Unique Solubility and Antigenic Characteristics

Suchergebnisse filtern